β Scribed by Takahiro Mezaki; Rie Sakai
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Botulinum toxin type A (btx A) injections are the most effective treatment for most patients with focal dystonia. Some patients who improve after btx A injections and later lose response have serologic evidence of antibodies to btx A with the mouse neutralization assay (seropositive pat
## Abstract In some patients, therapy with botulinum toxin type A (BTβA) becomes ineffective due to formation of antibodies (BTβAβAB). The time course of BTβAβAB titres after cessation of BTβA therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight
We report a case in which the development of a skin rash in a neutropenic patient was associated with multiple blood culture isolates of Candida guilliermondii--an unusual isolate not previously documented to cause rashes.